Dave & Buster’s stock soars 28% after COVID-19 vaccine trial announcement

Dave & Buster’s Entertainment Inc.
stock soared 28.7% in Monday premarket trading after Pfizer Inc.

and BioNTech SE
announced a “successful” COVID-19 vaccine trial. Dave & Buster’s has struggled during the pandemic, with many locations still closed as of early October and September comparable sales down 62%. Dave & Buster’s stock has sunk by more than half in 2020, down 54%, while the S&P 500 index
has gained 8.6% for the period.

View more information: https://www.marketwatch.com/story/dave-busters-stock-soars-28-after-covid-19-vaccine-trial-announcement-2020-11-09

Articles in category: moneyist
See also  Raymond James restructures payouts for Canada unit

Leave a Reply

Back to top button